Skandinaviska Enskilda Banken Ab (Publ) Bio Rad Laboratories, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $19.9 Billion
  • Q1 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 3,731 shares of BIO stock, worth $933,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,731
Previous 3,731 -0.0%
Holding current value
$933,048
Previous $1.23 Million 25.88%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$313.15 - $374.28 $31,314 - $37,428
-100 Reduced 2.61%
3,731 $1.23 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $42,560 - $57,676
-158 Reduced 3.96%
3,831 $1.24 Million
Q3 2023

Nov 09, 2023
SELL
$350.25 - $422.63 $5,954 - $7,184
-17 Reduced 0.42%
3,989 $1.43 Million
Q2 2023

Aug 07, 2023
BUY
$359.49 - $486.4 $47,452 - $64,204
132 Added 3.41%
4,006 $1.52 Million
Q1 2023

May 11, 2023
SELL
$418.69 - $503.0 $39,356 - $47,282
-94 Reduced 2.37%
3,874 $1.86 Million
Q4 2022

Feb 08, 2023
BUY
$351.71 - $456.01 $99,885 - $129,506
284 Added 7.71%
3,968 $1.67 Million
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $462,925 - $631,977
-1,122 Reduced 23.35%
3,684 $1.54 Million
Q2 2022

Aug 10, 2022
SELL
$463.67 - $597.16 $185,931 - $239,461
-401 Reduced 7.7%
4,806 $2.38 Million
Q1 2022

May 11, 2022
SELL
$524.57 - $735.42 $254,416 - $356,678
-485 Reduced 8.52%
5,207 $2.93 Million
Q4 2021

Feb 10, 2022
SELL
$708.84 - $794.68 $113,414 - $127,148
-160 Reduced 2.73%
5,692 $4.32 Million
Q3 2021

Nov 10, 2021
BUY
$657.71 - $825.77 $44,724 - $56,152
68 Added 1.18%
5,852 $4.37 Million
Q2 2021

Aug 10, 2021
BUY
$576.64 - $649.04 $192,597 - $216,779
334 Added 6.13%
5,784 $3.73 Million
Q1 2021

May 14, 2021
BUY
$547.01 - $662.35 $31,179 - $37,753
57 Added 1.06%
5,450 $3.11 Million
Q4 2020

Feb 11, 2021
SELL
$510.68 - $643.45 $35,236 - $44,398
-69 Reduced 1.26%
5,393 $3.14 Million
Q3 2020

Nov 12, 2020
BUY
$454.43 - $535.6 $1.75 Million - $2.06 Million
3,841 Added 236.95%
5,462 $2.82 Million
Q2 2020

Aug 13, 2020
BUY
$334.87 - $493.06 $74,006 - $108,966
221 Added 15.79%
1,621 $732,000
Q1 2020

May 13, 2020
BUY
$320.01 - $409.07 $32,001 - $40,907
100 Added 7.69%
1,400 $491,000
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $415,649 - $486,460
1,300 New
1,300 $481,000

Others Institutions Holding BIO

# of Institutions
450
Shares Held
18.8M
Call Options Held
12.7K
Put Options Held
14.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.16B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email